The co-infusion of these two incretins exerts a synergist effect that helps you lower your blood glucose level and help with weight loss
in rare cases, irregular heart rhythms, dizziness, fainting or collapse especially in people with pre-existing heart or electrolyte problems
Body weight and composition may theoretically influence drug distribution, as semaglutide binds extensively to albumin and distributes into tissues
To inject here, you target the top, outer portion of the thigh, midway between the hip and the knee
Notably, patients treated with PEG-Loxenatide accounted for the largest number in this study, but incidences of gastrointestinal adverse events (17.6% vs 30.6% to 51%) and hypoglycemia (3.1% vs 8.2% to 11.5%) were lower compared with those treated with other GLP-1RAs